In a Neu-driven breast cancer model, constitutively active TβRI increased the latency of the primary mammary tumor but also increased pulmonary metastasis whereas a dominant negative TβRII decreased the latency of the primary tumor but also significantly decreased the number of lung metastases [262]. The gene discussed is ERBB2; the disease is breast cancer.